510(k) Reform Does Not Mean Major Increase In Clinical Data Demands - FDA
This article was originally published in The Gray Sheet
Executive Summary
FDA insisted Aug. 31 that its planned reforms to the 510(k) program will not dramatically raise the bar for clinical data submissions